Emerging Therapies in Oncology:

Transcription

1 Emerging Therapies in Oncology: FROM PHASE I AND BEYOND NOVEMBER 3, 2017 The University of Texas MD Anderson Cancer Center Dan L. Duncan Building (CPB) Floor 8 Conference Center 1155 Pressler Street Houston, Texas For more information visit:

2 GOAL This workshop will provide a unique opportunity for oncologists and other health professionals to hear from leading experts in medical oncology as well as clinical and translational research. This educational workshop is directed toward medical oncologists, translational researchers (MDs and PhDs), study coordinators, oncology nurses and advanced practice providers, and drug developers from academia and industry interested in cancer drug development. Other health professionals interested in the treatment of cancer are also invited to attend. EDUCATIONAL OBJECTIVES After attending this conference, participants should be able to: Incorporate the appropriate referral of patients for consideration of clinical trials into clinical practice (knowledge, competence, performance); Incorporate the latest data on novel therapies for common cancers into clinical practice (knowledge, competence, performance); Assimilate the latest emerging therapies or refer patients for consideration of clinical trials to improve patient outcomes (knowledge, competence, performance, patient outcomes); and Practice precision medicine and incorporate appropriate tests in clinical practice (knowledge, competence, performance, patient outcomes). TARGET AUDIENCE This conference should be of value to physicians, fellows, investigators, study coordinators, oncology nurses and advanced practice providers. EDUCATIONAL METHODS Lectures Questions and Answers EVALUATION A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. ACCREDITATION/ CREDIT DESIGNATION The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CME CERTIFICATES AND ATTENDANCE VERIFICATION CERTIFICATES Certificates awarding AMA PRA Category 1 Credit or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form. Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

3 AGENDA Friday, November 3, :00 am Registration and Continental Breakfast MD ANDERSON PLANNING COMMITTEE Department of Investigational Cancer Therapeutics Timothy A. Yap, MBBS, MRCP, PhD, BSc (Hons), PgDip (Onc), Program Chair David S. Hong, MD, Program Co-Chair and Deputy Chair Shubham Pant, MBBS Jordi Rodon Ahnert, MD, PhD Dwana K Sanders, CCRP Operation Manager - Regulatory Jing Gong, MS, CCRP Supervisor, Clinical Studies Tamara G. Barnes, RN, MSN, AOCNS Advanced Practice Registered Nurse Department of CME/Conference Management Felisha Estelle Senior Conference Coordinator Kelley Gilpin Program Manager, Academic Affairs - Industry Support PHASE I TRIALS EXPLAINED 8:50 Opening Remarks Timothy A. Yap, MBBS, MRCP, PhD, BSc, PgDip 9:00 Paradigm Shift in Clinical Trials Jordi Rodon, MD, PhD 9:15 Phase I Trial Outcomes 9:30 Phase I Trials: When, How and Where Shubham Pant, MBBS 9:45 Phase I Trial Processes Explained: The Patient Journey Sandra Montez, RN 10:00 Break EMERGING THERAPIES I 10:30 Latest Therapies for Colorectal Cancer Van Morris, MD, PhD 11:00 Latest Therapies for Non-Small Cell Lung Cancer Lauren A. Byers, MD 11:30 Latest Therapies for Breast Cancer Bora Lim, MD 12:00 Latest Therapies for Prostate Cancer Paul Corn, MD, PhD 12:30 pm Lunch (provided) EMERGING THERAPIES II 1:30 Latest Developments in Immunotherapies Aung Naing, MD 1:45 CAR-T Cells and Beyond Jason R. Westin, MD

4 2:00 DNA Repair Inhibitors Timothy A. Yap, MBBS, MRCP, PhD, BSc, PgDip 2:15 Epigenetic Agents Filip Janku, MD, PhD 2:30 Antibody Drug Conjugates 2:45 Odds and Ends: RNA Therapeutics, Metabolomics, etc. David S. Hong, MD 3:00 Radiation Therapy as Systemic Therapy James Welsh, MD 3:15 Break FINDING THE RIGHT PATIENT 3:30 Precision Medicine Funda Meric-Bernstam, MD 3:50 ABC of NGS Kenna R. Mills Shaw, PhD 4:10 Circulating Markers Senthil Damodaran, MD 4:30 Radiogenomics Rivka Colen, MD 4:50 Closing Remarks/ Q&A Session David S. Hong, MD 5:00 Adjourn CONFERENCE PRESENTATIONS MD Anderson Cancer Center is going green to save paper and the environment. Hard copies of the presentations will not be available onsite. Presentations will be available online after the conference adjourns. MD ANDERSON FACULTY Lauren A. Byers, MD Thoracic/Head & Neck Medical Oncology Rivka Colen, MD Cancer Systems Imaging Paul Corn, MD, PhD Genitourinary Medical Oncology Senthil Damodaran, MD Breast Medical Oncology David S. Hong, MD and Deputy Chair Filip Janku, MD, PhD Invest. Cancer Therapeutics Bora Lim, MD Breast Medical Oncology Funda Meric-Bernstam, MD Chair Sandra Montez, RN Supervisor, Research Nurse Van Morris, MD, PhD Gastrointestinal Medical Oncology Aung Naing, MD Shubham Pant, MBBS Kenna R. Mills Shaw, PhD Executive Director IPCT Jordi Rodon, MD, PhD James Welsh, MD Radiation Oncology Department Jason R. Westin, MD Lymphoma/Myeloma Timothy A. Yap, MBBS, MRCP, PhD, BSc (Hons), PgDip (Onc)

5 REGISTRATION INFORMATION On-site registration opens at 8:00 am on Friday, November 3, 2017 at MD Anderson Cancer Center, Duncan Building (CPB), Floor 8 Conference Center, 1155 Pressler Street, Houston, Texas. The opening session of the conference will begin at 8:50 am and adjourn at 5:00 pm. Advanced registration is encouraged as space and materials are limited. Please see the registration form for applicable fees. The conference registration fee includes the tuition, final program pages, breakfast, lunch and breaks. The deadline for advanced registration is Friday, October 13, There are three ways to register: 1. On-line: at 2. Fax to: Mail to: CME/Conference Management Unit 1781 P.O. Box Houston, TX Telephone registrations are not accepted. We accept the following forms of payment: Check (payable through U.S. banks only) Money Order Credit Cards (MasterCard, VISA, and American Express) Cash (on-site registration only) When registering online a receipt/confirmation letter will be automatically ed to the address you list on the registration form. If you register by fax or mail a receipt/confirmation letter will be sent to you within ten working days of receipt of your payment. A REMINDER: Meeting room temperatures and personal comfort ranges vary widely. Since meeting rooms always seem cold, please bring either a sweater or jacket. REGISTRATION FEE SCHEDULE See registration form for fee schedule. REFUND/CANCELLATION POLICY The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Friday, October 13, No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, , or at the phone or fax numbers given on the registration form. In case of activity cancellation, the liability of the Department of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee. The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. Please check the website conferences For additional information, contact CME/ Conference Management at or toll free at SPECIAL ASSISTANCE Contact Felisha Estelle in the Department of CME/Conference Management at if you have any special dietary or ADA accommodation needs. Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity. Fax or CME/Conference Management. All responses will be forwarded to the Program Chairs for consideration. ACCOMMODATIONS A block of rooms has been reserved for conference attendees at Houston Marriott Medical Center Hotel, 6580 Fannin Street, Houston, Texas. Early reservation is suggested. The hotel phone number is The toll free number is When you make reservations be sure to mention the MDA Phase I Clinical Trials Workshop Conference to be assured of receiving the special meeting rate of $99.00 single or double occupancy. Please add 17% Texas state and local taxes.

6 Room Reservation Website: Book your group rate for MDA Phase I Clinical Trials Workshop Conference. Reservations and deposits received after Thursday, October 19, 2017, will be confirmed if space is available and at currently published hotel guest room rates. GROUND TRANSPORTATION (Prices are subject to change) Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU). Taxicabs are available at an estimated cost of $50-$60 to or from William P. Hobby Airport or George Bush Intercontinental Airport. has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity. Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, scheduling conflicts, and so forth. Photographing, audio taping and videotaping are prohibited. SuperShuttle operates a shuttle bus between George Bush Intercontinental Airport and the Houston Marriott Medical Center Hotel, for $27 oneway and $53 round-trip. For more information, call or toll free at , or online at SuperShuttle operates a shuttle bus between William P. Hobby Airport and the Houston Marriott Medical Center Hotel for $23 one-way and $43 roundtrip. For more information, call or toll-free at , or online at CONFERENCE REGISTRATION /30/117207/41 Emerging Therapies in Oncology: From Phase I and Beyond November 3, 2017 THIS IS NOT A SELF-MAILER - Address to: Emerging Therapies in Oncology: From Phase I and Beyond November 3, 2017 Department of CME/Conference Management Unit 1781 PO Box , Houston, TX or fax to Make check or money order payable to: Last Name First MI Highest Degree Department (include unit no.) Specialty Institution MD Anderson Employee ID No. (required for all MDACC employees): Physician Yes No Street City State/Foreign Country/Zip or Mail Code Registration Fees Daytime Phone (with area code) Cell Phone (with area code) Fax (with area code) Physicians (MDs/DOs) 1Postmarked before October 13, $175 1Postmarked after October 13, $200 Address (please print) Other Healthcare Professionals/Trainees 1Postmarked before October 13, $75 1Postmarked after October 13, $100 Emergency Contact Phone (with area code) Credit Card Holder Name (First/Last) Charge the following: VISA MC AMEX MDA Physicians (MDs/DOs) 1Postmarked before October 13, $105 1Postmarked after October 13, $125 Credit Card Number Expiration Date Security Code/CVV/CSV Credit Card Holder Billing Address & ZIP Code MDA Healthcare Professionals/Trainees 1Postmarked before October 13, $50 1Postmarked after October 13, $75 MD Anderson Interdepartmental Transfer (IDT) No.: *Fund Group 90 will not be accepted Business Unit Department Fund Group* Fund Fund Type Authorized Signature REQUIRED for CREDIT CARD or IDT IDT Approver Name (First/Last) please print

7 Department of CME/Conference Management- Unit /30/117207/41 PO Box Houston, TX Non-Profit Org. U.S. Postage P A I D Houston, TX Permit No. 7052